Page 232
Appendix B
Workshop Agendas
Workshop on Perspectives on the Medical Use of Marijuana:
Basic and Clinical Science
December 14-16, 1997 Beckman Center, Irvine, California
AGENDA
Sunday, December 14,1997
2:00 p.m. Introduction
Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health
2:30 p.m. Public Input Session, 5 minutes per person
Moderator: Stanley Watson, Jr., IOM Study Investigator, University of Michigan
5:30 p.m. ADJOURN
Page 233
Monday, December 15, 1997
CANNABINOID NEUROSCIENCE
8:30 a.m. Moderator: Stanley Watson, IOM Study Investigator,
University of Michigan
8:45 a.m. Neuropharmacology of Cannabinoids and Their Receptors
Steven R. Childers, Wake Forest University School of Medicine
9:15 a.m. Precipitated Cannabinoid Withdrawal and Sensory Processing of Painful Stimuli
J. Michael Walker, Brown University
9:45 a.m. Role of Cannabinoids in Movement
Clara Sanudo, Brown University
10:15 a.m. Tolerance and Cannabinoid-Opioid Interactions
Sandra P. Welch, Medical College of Virginia
10:45 a.m. BREAK
MEDICAL USES OF MARIJUANA:
CLINICAL DATA AND BASIC BIOLOGY
11:10 a.m. Moderator: John A. Benson, Jr., IOM Study Investigator,
Oregon Health Sciences University
11:15 a.m. Profile of Medical Marijuana Users
John Mendelson, University of California at San Francisco
11:45 a.m. Immune Modulation by Cannabinoids
Norbert Kaminski, Michigan State University
12:15 p.m. Psychological Effects of Marijuana Use
Charles R. Schuster, Wayne State University
12:45 p.m. LUNCH
Page 234
1:45 p.m. Marijuana and Glaucoma
Paul Kaufman, University of Wisconsin
2:15 p.m. Effects of Marijuana and Cannabinoids in Neurological Disorders
Paul Consroe, University of Arizona Health Sciences Center
2:45 p.m. Neural Mechanisms of Cannabinoid Analgesia
Howard Fields, University of California at San Francisco
3:15 p.m. Pain Management
Michael Rowbotham, University of California at San Francisco
3:45 p.m. Wasting Syndrome Pathogenesis and Clinical Markers
Donald Kotler, St. Luke's-Roosevelt Hospital
4:15 p.m. Clinical Experience with Marijuana
Stephen O'Brien, East Bay AIDS Center
4:45 p.m. ADJOURN
Tuesday, December 16,1997
MEDICAL USES OF MARIJUANA:
CLINICAL DATA AND BASIC BIOLOGY
8:30 a.m. Moderator: John A. Benson, Jr., IOM Study Investigator,
Oregon Health Sciences University
8:45 a.m. Marijuana in AIDS Wasting: Tribulations and Trials Donald I. Abrams,
University of California at San Francisco
9:15 a.m. Nausea and Vomiting: Underlying Mechanisms and Upcoming Treatments Alan D. Miller, The Rockefeller University
9:45 a.m. Postchemotherapy Nausea and Antiemetics
Richard J. Gralla, Ochsner Cancer Center
Page 235
10:15 a.m. BREAK
SUMMARY VIEWS
10:30 a.m. Marijuana Is Different from THC: A Review of Basic Research and State Studies of Antiemesis
Richard E. Musty, University of Vermont
11:00 a.m. Medical Uses of Crude Marijuana: Medical and Social Issues
Eric A. Voth, The International Drug Strategy Institute
11:30 a.m. General Questions Moderator:
John A. Benson, Jr., IOM Study Investigator
12:00 noon ADJOURN
Page 236
Workshop on Acute and Chronic Effects of Marijuana Use
January 22-23, 1998
New Orleans Marriott Hotel
New Orleans, Louisiana
AGENDA
Thursday, January 22, 1998
2:00 p.m. Introduction
Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health
2:30 p.m. Public Input Session, 5 minutes per person Moderator: Stanley Watson, Jr., IOM Study Investigator, University of Michigan
4:30 p.m. ADJOURN
Friday, January 23, 1998
8:30 a.m. Moderator: John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University
HEALTH CONSEQUENCES OF MARIJUANA USE
9:00 a.m. Health Consequences of Marijuana Use: Epidemiological Studies Stephen Sidney, Kaiser Permanente, Oakland, CA
9:30 a.m. Immunity, Infections, and Cannabinoids Thomas Klein, University of South Florida
10:00 a.m. Pulmonary Effects of Smoked Marijuana Donald Tashkin, Unversity of California at Los Angeles
10:30 a.m. BREAK
Page 237
10:45 a.m. Is Marijuana Carcinogenic?: Epidemiological and Biological Evidence
Panel Discussion
Stephen Sidney Donald Tashkin
12:00 noon LUNCH
EFFECTS OF MARIJUANA ON BEHAVIOR
1:30 p.m. Marijuana: Addictive and Amotivational States, the Scientific Evidence
John Morgan, City University of New York Medical School
2:00 p.m. Marijuana's Acute Behavioral Effects in Humans
Richard Foltin, Columbia University
2:30 p.m. Tolerance and Dependence Following Chronic Administration of Oral THC or Smoked Marijuana to Humans
Margaret Haney, Columbia University
3:00 p.m. Patterns of Continuity and Discontinuity of Marijuana Use in Relationship to Other Drugs
Robert Pandina, Rutgers University
3:30 p.m. ADJOURN
Page 238
Workshop on Prospects for Cannabinoid Drug Development
February 23-24, 1998
National Academy of Sciences Building
Washington, D.C.
AGENDA
Monday, February 23,1998
1:30 p.m. Introduction
Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health
2:00 p.m. Public Input Session, 5 minutes per person
Moderator: John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University
5:30 p.m. ADJOURN
Tuesday, February 24,1998
8:30 a.m. Introduction Constance Pechura, IOM Division Director Neuroscience and Behavioral Health
Moderator: Stanley J. Watson, Jr., IOM Study Investigator, University of Michigan
OVERVIEWS OF PRECEDING WORKSHOPS
8:45 a.m. Acute and Chronic Effects of Marijuana
Billy R. Martin, Medical College of Virginia
9:25 a.m. Perspectives on the Medical Use of Marijuana
Eric B. Larson, University of Washington Medical School
9:55 a.m. The Neurobiology of Cannabinoid Dependence
George F. Koob, Scripps Research Institute
10:25 a.m. BREAK
Page 239
DRUG DEVELOPMENT
10:45 a.m. Regulatory Requirements Affecting Marijuana
J. Richard Crout, Crout Consulting
11:15 a.m. Marinol and the Market
Robert E. Dudley, Unimed Pharmaceuticals, Inc.
11:45 a.m. Development of Cannabis-based Therapeutics
Dave Pate, HortaPharm, B.V.
12:15 p.m. LUNCH
DRUG DELIVERY
1:30 p.m. Alternative Drug Delivery Technologies for the Therapeutic Use of Marijuana
Phyllis I. Gardner, ALZA Corporation, Stanford University
2:00 p.m. Delivery of Analgesics via the Respiratory Track
Reid M. Rubsamen, Aradigm Corporation
2:30 p.m. Current Concepts for Delivery of THC
Mahendra G. Dedhiya, Roxanne Laboratories, Inc.
3:00 p.m. D9-THC-Hemisuccinate in Suppository Formulation: An Alternative to Oral and Smoked
THC Mahmoud A. ElSohly, University of Mississippi, ElSohly Laboratories, Inc.
3:30 p.m. Concluding Remarks
John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University
3:45 p.m. ADJOURN